1 Sp.zn. sukls333509/2019 Příbalová informace: informace pro uživatele Erlotinib Teva 100 mg potahované tablety Erlotinib T
1 Sp.zn. sukls420775/2018, sukls420776/2018, sukls420777/2018 Příbalová informace: informace pro uživatele Erlotinib Vipharm
![Molecules | Free Full-Text | Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma Molecules | Free Full-Text | Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma](https://www.mdpi.com/molecules/molecules-25-00490/article_deploy/html/images/molecules-25-00490-g001.png)
Molecules | Free Full-Text | Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
![Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer | British Journal of Cancer Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsj.bjc.6603055/MediaObjects/41416_2006_Article_BF6603055_Fig4_HTML.jpg)
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer | British Journal of Cancer
![Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer | British Journal of Cancer Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603055/MediaObjects/41416_2006_Article_BF6603055_Fig1_HTML.gif)